Shares of XOMA Co. (NASDAQ:XOMAO – Get Free Report) rose 0.6% during mid-day trading on Wednesday . The company traded as high as $25.41 and last traded at $25.45. Approximately 6,056 shares were traded during mid-day trading, an increase of 40% from the average daily volume of 4,328 shares. The stock had previously closed at $25.29.
XOMA Price Performance
The business has a 50 day moving average price of $25.42 and a two-hundred day moving average price of $25.44.
About XOMA
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Read More
- Five stocks we like better than XOMA
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
